Hims & Hers Health Price to Free Cash Flow Ratio 2020-2025 | HIMS
Historical price to free cash flow ratio values for Hims & Hers Health (HIMS) since 2020.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Hims & Hers Health Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-11-06 | 41.52 | 75.99 | |
| 2025-09-30 | 56.72 | $0.55 | 103.81 |
| 2025-06-30 | 49.85 | $0.56 | 88.97 |
| 2025-03-31 | 29.55 | $1.04 | 28.53 |
| 2024-12-31 | 24.18 | $0.88 | 27.34 |
| 2024-09-30 | 18.42 | $0.69 | 26.61 |
| 2024-06-30 | 20.19 | $0.45 | 45.10 |
| 2024-03-31 | 15.47 | $0.29 | 52.87 |
| 2023-12-31 | 8.90 | $0.27 | 33.11 |
| 2023-09-30 | 6.29 | $0.16 | 38.33 |
| 2023-06-30 | 9.40 | $0.09 | 109.94 |
| 2023-03-31 | 9.92 | $0.00 | 0.00 |
| 2022-12-31 | 6.41 | $-0.14 | 0.00 |
| 2022-09-30 | 5.58 | $-0.13 | 0.00 |
| 2022-06-30 | 4.53 | $-0.24 | 0.00 |
| 2022-03-31 | 5.33 | $-0.18 | 0.00 |
| 2021-12-31 | 6.55 | $-0.19 | 0.00 |
| 2021-09-30 | 7.54 | $-0.18 | 0.00 |
| 2021-06-30 | 10.89 | $-0.03 | 0.00 |
| 2021-03-31 | 13.23 | $-0.07 | 0.00 |
| 2020-12-31 | 14.60 | $-0.12 | 0.00 |
| 2020-09-30 | 11.75 | $-0.06 | 0.00 |
| 2020-06-30 | 10.17 | $-0.17 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $9.884B | $1.477B |
| Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $48.395B | 59.05 |
| Tempus AI (TEM) | United States | $14.291B | 0.00 |
| Doximity (DOCS) | United States | $11.985B | 53.33 |
| IRhythm Technologies (IRTC) | United States | $5.815B | 0.00 |
| Hinge Health (HNGE) | United States | $3.560B | 0.00 |
| Privia Health (PRVA) | United States | $3.071B | 227.46 |
| Heartflow (HTFL) | United States | $2.895B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.406B | 39.82 |
| Enovis (ENOV) | United States | $1.800B | 9.51 |
| 10x Genomics (TXG) | United States | $1.679B | 0.00 |
| Omnicell (OMCL) | United States | $1.642B | 32.79 |
| Clover Health Investments (CLOV) | United States | $1.520B | 0.00 |
| Schrodinger (SDGR) | United States | $1.455B | 0.00 |
| Azenta (AZTA) | United States | $1.400B | 61.08 |
| Phreesia (PHR) | United States | $1.358B | 0.00 |
| Claritev (CTEV) | United States | $1.071B | 0.00 |
| Evolent Health (EVH) | United States | $0.746B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.697B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.632B | 0.00 |
| Talkspace (TALK) | United States | $0.576B | 114.67 |
| Veradigm (MDRX) | United States | $0.520B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.505B | 0.00 |
| Standard BioTools (LAB) | United States | $0.438B | 0.00 |
| Carlsmed (CARL) | United States | $0.322B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.305B | 0.00 |
| TruBridge (TBRG) | United States | $0.290B | 50.76 |
| CapsoVision (CV) | United States | $0.226B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.223B | 0.00 |
| Outset Medical (OM) | United States | $0.223B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.215B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.191B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.186B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.170B | 0.00 |
| CareCloud (CCLD) | United States | $0.125B | 5.67 |
| EUDA Health Holdings (EUDA) | Singapore | $0.119B | 0.00 |
| American Well (AMWL) | United States | $0.074B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.073B | 0.00 |
| Pulmonx (LUNG) | United States | $0.069B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| HeartBeam (BEAT) | United States | $0.057B | 0.00 |
| 111 (YI) | China | $0.038B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.036B | 0.00 |
| Precipio (PRPO) | United States | $0.033B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.027B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.027B | 0.00 |
| Zhongchao (ZCMD) | China | $0.018B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |